Acorah Software Products - Accounts Production 19.4.351 false true true 30 April 2025 1 May 2024 false 1 May 2025 30 April 2026 30 April 2026 14797524 Dr J Patel iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14797524 2025-04-30 14797524 2026-04-30 14797524 2025-05-01 2026-04-30 14797524 frs-core:CurrentFinancialInstruments 2026-04-30 14797524 frs-core:ComputerEquipment 2026-04-30 14797524 frs-core:ComputerEquipment 2025-05-01 2026-04-30 14797524 frs-core:ComputerEquipment 2025-04-30 14797524 frs-core:FurnitureFittings 2026-04-30 14797524 frs-core:FurnitureFittings 2025-05-01 2026-04-30 14797524 frs-core:FurnitureFittings 2025-04-30 14797524 frs-core:ShareCapital 2026-04-30 14797524 frs-core:RetainedEarningsAccumulatedLosses 2026-04-30 14797524 frs-bus:PrivateLimitedCompanyLtd 2025-05-01 2026-04-30 14797524 frs-bus:FilletedAccounts 2025-05-01 2026-04-30 14797524 frs-bus:SmallEntities 2025-05-01 2026-04-30 14797524 frs-bus:AuditExempt-NoAccountantsReport 2025-05-01 2026-04-30 14797524 frs-bus:SmallCompaniesRegimeForAccounts 2025-05-01 2026-04-30 14797524 frs-bus:Director1 2025-05-01 2026-04-30 14797524 frs-bus:Director1 2025-04-30 14797524 frs-bus:Director1 2026-04-30 14797524 frs-countries:EnglandWales 2025-05-01 2026-04-30 14797524 2024-04-30 14797524 2025-04-30 14797524 2024-05-01 2025-04-30 14797524 frs-core:CurrentFinancialInstruments 2025-04-30 14797524 frs-core:ShareCapital 2025-04-30 14797524 frs-core:RetainedEarningsAccumulatedLosses 2025-04-30
Registered number: 14797524
Amai Wellness Ltd
Unaudited Financial Statements
For The Year Ended 30 April 2026
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—5
Page 1
Balance Sheet
Registered number: 14797524
2026 2025
Notes £ £ £ £
FIXED ASSETS
Tangible Assets 4 1,547 619
1,547 619
CURRENT ASSETS
Debtors 5 25,112 1,991
Cash at bank and in hand 2,729 1,979
27,841 3,970
Creditors: Amounts Falling Due Within One Year 6 (29,078 ) (4,549 )
NET CURRENT ASSETS (LIABILITIES) (1,237 ) (579 )
TOTAL ASSETS LESS CURRENT LIABILITIES 310 40
PROVISIONS FOR LIABILITIES
Deferred Taxation (294 ) -
NET ASSETS 16 40
CAPITAL AND RESERVES
Called up share capital 7 1 1
Profit and Loss Account 15 39
SHAREHOLDERS' FUNDS 16 40
Page 1
Page 2
For the year ending 30 April 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Dr J Patel
Director
30 October 2026
The notes on pages 3 to 5 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Amai Wellness Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 14797524 . The registered office is 2 Wimpole Street, London, W1G 0EB.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared on the historical cost basis.
The financial statements are prepared in sterling, which is the functional currency of the entity.
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
2.2. Going Concern Disclosure
The directors have identified material uncertainties related to events or conditions that may cast significant doubt about the company's ability to continue as a going concern, however, the going concern basis remains appropriate.
2.3. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the rendering of services via specalist medical practices. 
2.4. Tangible Fixed Assets and Depreciation
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Fixtures and fittings 33% Reducing Balance
Computer equipment 33% Reducing Balance
2.5. Financial Instruments
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities.
Where the contractual obligations of financial instruments (including share capital) are equivalent to a similar debt instrument, those financial instruments are classed as financial liabilities. Financial liabilities are presented as such in the balance sheet. Finance costs and gains or losses relating to financial liabilities are included in the profit and loss account. Finance costs are calculated so as to produce a constant rate of return on the outstanding liability.
Where the contractual terms of share capital do not have any terms meeting the definition of a financial liability then this is classed as an equity instrument. Dividends and distributions relating to equity instruments are debited direct to equity.
2.6. Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively.

Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 2 (2025: 1)
2 1
Page 3
Page 4
4. Tangible Assets
Fixtures and fittings Computer equipment Total
£ £ £
Cost
As at 1 May 2025 - 929 929
Additions 1,690 - 1,690
As at 30 April 2026 1,690 929 2,619
Depreciation
As at 1 May 2025 - 310 310
Provided during the period 558 204 762
As at 30 April 2026 558 514 1,072
Net Book Value
As at 30 April 2026 1,132 415 1,547
As at 1 May 2025 - 619 619
5. Debtors
2026 2025
£ £
Due within one year
Other debtors 25,112 1,991
6. Creditors: Amounts Falling Due Within One Year
2026 2025
£ £
Other loans 7,411 -
Other creditors 17,888 1,586
Taxation and social security 3,779 2,963
29,078 4,549
7. Share Capital
2026 2025
£ £
Allotted, Called up and fully paid 1 1
8. Directors Advances, Credits and Guarantees
As at 1 May 2025 Amounts advanced Amounts repaid Amounts written off As at 30 April 2026
£ £ £ £ £
Dr Jaisyn Patel 1,990 63,818 40,696 - 25,111
Page 4
Page 5
9. Related Party Transactions
The following related party transactions were undertaken during the year:
A director withdrew amounts from the company totalling £63,818 (2025: £35,914), and introduced amounts to the company totalling £40,696 (2025: £22,297). At the balance sheet date the amount owed to the company was £25,111 (2025: £1,990 owed to the company).
During the year a related company charged Amai Wellness £1,000 in relation to advertising services. 
Dividends were paid to the director in respect of their shareholdings totalling £15,400 (2025: £12,800).
The aggregate remuneration paid to key management personnel for the year was £12,564 (2025: £1,047).
No further transactions with related parties were undertaken such as are required to be disclosed in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
Page 5